<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   832
  </number>
  <updateDate>
   2023-01-11T13:46:53Z
  </updateDate>
  <updateDateIncludingText>
   2023-01-11T13:46:53Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-02-04
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 21 (Thursday, February 4, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Ms. PINGREE:H.R. 832.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8[Page H388]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hsif00
    </systemCode>
    <name>
     Energy and Commerce Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-02-05T20:29:34Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-02-04T15:08:30Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <relatedBills>
   <item>
    <title>
     Safe and Affordable Drugs from Canada Act of 2021
    </title>
    <congress>
     117
    </congress>
    <number>
     259
    </number>
    <type>
     S
    </type>
    <latestAction>
     <actionDate>
      2021-02-04
     </actionDate>
     <text>
      Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Identical bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
  </relatedBills>
  <actions>
   <item>
    <actionDate>
     2021-02-05
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-02-04
    </actionDate>
    <text>
     Referred to the House Committee on Energy and Commerce.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsif00
      </systemCode>
      <name>
       Energy and Commerce Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-02-04
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-02-04
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     P000597
    </bioguideId>
    <fullName>
     Rep. Pingree, Chellie [D-ME-1]
    </fullName>
    <firstName>
     Chellie
    </firstName>
    <lastName>
     Pingree
    </lastName>
    <party>
     D
    </party>
    <state>
     ME
    </state>
    <district>
     1
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     H001056
    </bioguideId>
    <fullName>
     Rep. Herrera Beutler, Jaime [R-WA-3]
    </fullName>
    <firstName>
     Jaime
    </firstName>
    <lastName>
     Herrera Beutler
    </lastName>
    <party>
     R
    </party>
    <state>
     WA
    </state>
    <district>
     3
    </district>
    <sponsorshipDate>
     2021-02-04
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Health
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects>
    <item>
     <name>
      Administrative law and regulatory procedures
     </name>
    </item>
    <item>
     <name>
      Canada
     </name>
    </item>
    <item>
     <name>
      Department of Health and Human Services
     </name>
    </item>
    <item>
     <name>
      Drug safety, medical device, and laboratory regulation
     </name>
    </item>
    <item>
     <name>
      Government information and archives
     </name>
    </item>
    <item>
     <name>
      Prescription drugs
     </name>
    </item>
    <item>
     <name>
      Trade restrictions
     </name>
    </item>
   </legislativeSubjects>
   <policyArea>
    <name>
     Health
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-02-04
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2021-03-22T18:41:14Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;b&gt;Safe and Affordable Drugs from Canada Act of 2021&lt;/b&gt;&lt;/p&gt; &lt;p&gt;This bill requires the Food and Drug Administration (FDA) to allow for the personal importation of prescription drugs from Canada in certain instances.&lt;/p&gt; &lt;p&gt;Such a drug must (1) be purchased from an approved Canadian pharmacy and dispensed by a pharmacist licensed in Canada; (2) be purchased by an individual for personal use only and in quantities not to exceed a 90-day supply; (3) be filled using a valid prescription from a physician licensed in a U.S. state; and (4) have the same active ingredients, route of administration, dosage form, and strength as an FDA-approved drug. Certain types of drugs may not be imported under this program, such as controlled substances, biological products, or intravenously injected drugs.&lt;/p&gt; &lt;p&gt;An approved pharmacy under this program must be located and licensed in Canada and meet additional requirements, such as participation in ongoing and comprehensive quality assurance programs. &lt;/p&gt; &lt;p&gt;The FDA shall publish a list of approved Canadian pharmacies on a website. &lt;/p&gt; &lt;p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   Safe and Affordable Drugs from Canada Act of 2021
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     Safe and Affordable Drugs from Canada Act of 2021
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To amend the Federal Food, Drug, and Cosmetic Act to allow for the personal importation of safe and affordable drugs from approved pharmacies in Canada.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     Safe and Affordable Drugs from Canada Act of 2021
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-02-04T05:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr832ih/xml/BILLS-117hr832ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-02-05
   </actionDate>
   <text>
    Referred to the Subcommittee on Health.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-02-05
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-02-04
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-02-04
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-02-04
9
Library of Congress
Introduced in House
IntroReferral
2021-02-04T15:08:30Z
Referred to
House
Energy and Commerce Committee
2021-02-05T20:29:34Z
Referred to
Health Subcommittee
hsif14
hsif00
Standing
H001056
3
Jaime
Rep. Herrera Beutler, Jaime [R-WA-3]
Herrera Beutler
R
2021-02-04
WA
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-02-04
2021-02-05
Referred to the Subcommittee on Health.
House
Health
2021-02-04
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
CRS
Identical bill
Safe and Affordable Drugs from Canada Act of 2021
S
P000597
1
Chellie
Rep. Pingree, Chellie [D-ME-1]
N
Pingree
D
ME
Administrative law and regulatory procedures Canada Department of Health and Human Services Drug safety, medical device, and laboratory regulation Government information and archives Prescription drugs Trade restrictions
2021-02-04
Introduced in House
 <p><b>Safe and Affordable Drugs from Canada Act of 2021</b></p> <p>This bill requires the Food and Drug Administration (FDA) to allow for the personal importation of prescription drugs from Canada in certain instances.</p> <p>Such a drug must (1) be purchased from an approved Canadian pharmacy and dispensed by a pharmacist licensed in Canada; (2) be purchased by an individual for personal use only and in quantities not to exceed a 90-day supply; (3) be filled using a valid prescription from a physician licensed in a U.S. state; and (4) have the same active ingredients, route of administration, dosage form, and strength as an FDA-approved drug. Certain types of drugs may not be imported under this program, such as controlled substances, biological products, or intravenously injected drugs.</p> <p>An approved pharmacy under this program must be located and licensed in Canada and meet additional requirements, such as participation in ongoing and comprehensive quality assurance programs. </p> <p>The FDA shall publish a list of approved Canadian pharmacies on a website. </p> <p>
2021-03-22T18:41:14Z
00
2021-02-04T05:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr832ih/xml/BILLS-117hr832ih.xml
Safe and Affordable Drugs from Canada Act of 2021
Safe and Affordable Drugs from Canada Act of 2021
Display Title
IH
Introduced in House
To amend the Federal Food, Drug, and Cosmetic Act to allow for the personal importation of safe and affordable drugs from approved pharmacies in Canada.
Official Title as Introduced
IH
Introduced in House
Safe and Affordable Drugs from Canada Act of 2021
Short Title(s) as Introduced
HR
2023-01-11T13:46:53Z
2023-01-11T13:46:53Z
3.0.0
2021-02-04
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
CRS
Identical bill
Safe and Affordable Drugs from Canada Act of 2021
S
2021-02-05
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-02-04
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the House Committee on Energy and Commerce.
IntroReferral
Intro-H
2021-02-04
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-02-04
9
Library of Congress
Introduced in House
IntroReferral
P000597
1
Chellie
Rep. Pingree, Chellie [D-ME-1]
N
Pingree
D
ME
H001056
3
Jaime
Rep. Herrera Beutler, Jaime [R-WA-3]
Herrera Beutler
R
2021-02-04
WA
Administrative law and regulatory procedures Canada Department of Health and Human Services Drug safety, medical device, and laboratory regulation Government information and archives Prescription drugs Trade restrictions
2021-02-04
Introduced in House
 <p><b>Safe and Affordable Drugs from Canada Act of 2021</b></p> <p>This bill requires the Food and Drug Administration (FDA) to allow for the personal importation of prescription drugs from Canada in certain instances.</p> <p>Such a drug must (1) be purchased from an approved Canadian pharmacy and dispensed by a pharmacist licensed in Canada; (2) be purchased by an individual for personal use only and in quantities not to exceed a 90-day supply; (3) be filled using a valid prescription from a physician licensed in a U.S. state; and (4) have the same active ingredients, route of administration, dosage form, and strength as an FDA-approved drug. Certain types of drugs may not be imported under this program, such as controlled substances, biological products, or intravenously injected drugs.</p> <p>An approved pharmacy under this program must be located and licensed in Canada and meet additional requirements, such as participation in ongoing and comprehensive quality assurance programs. </p> <p>The FDA shall publish a list of approved Canadian pharmacies on a website. </p> <p>
2021-03-22T18:41:14Z
00
Safe and Affordable Drugs from Canada Act of 2021
Safe and Affordable Drugs from Canada Act of 2021
Display Title
IH
Introduced in House
To amend the Federal Food, Drug, and Cosmetic Act to allow for the personal importation of safe and affordable drugs from approved pharmacies in Canada.
Official Title as Introduced
IH
Introduced in House
Safe and Affordable Drugs from Canada Act of 2021
Short Title(s) as Introduced
2021-02-05
Referred to the Subcommittee on Health.